The infusion pump market size was valued at USD 13.12 billion in 2024 and is expected to reach USD 23.13 billion by 2032, growing at a CAGR of 7.32% over the forecast period of 2025-2032.
The infusion pump market is witnessing strong growth due to the growing incidence of chronic ailments such as diabetes, cancer, and pain disorders. Growing demand for home infusion care, advancements in smart pumps, and favorable regulatory approvals are also fueling market growth. The trend toward ambulatory and portable products increases patient comfort and adherence. Rising healthcare infrastructure developments and increasing emerging markets are leading to consistent global demand, driving the infusion pump market for further growth.
The U.S. infusion pump market size was valued at USD 4.52 billion in 2024 and is expected to reach USD 7.95 billion by 2032, growing at a CAGR of 7.30% over the forecast period of 2025-2032. The U.S. is in a leading position in the North American infusion pump market, and it commands a high percentage of the market revenue of the region. The country's dominance is due to reasons such as the high incidence of chronic diseases, high healthcare spending, well-developed medical infrastructure, and established infusion pump companies based in the nation. These factors together combine to contribute to the U.S.'s leadership in propelling the development and the North American infusion pump market growth.
For instance, In August 2023, ICU Medical, Inc., the medical device innovator with a global presence, declared that it had achieved 510(k) clearance from the United States Food and Drug Administration (FDA) for its Plum Duo infusion pump with embedded LifeShield infusion safety software. The Plum Duo pump, along with its safety software, will become available to customers in the U.S. during early 2024.
Drivers
Hospital Admission and Surgery Rates Increase are Driving the Market Growth
Infusion pumps are essential equipment in hospitals, particularly during surgeries, intensive care, and emergency treatments. With increased hospitalization rates globally due to chronic diseases, trauma, and surgical interventions, the need for accurate and consistent drug delivery systems has increased significantly. Infusion pumps assist in delivering fluids, anesthesia, blood products, and medications in regulated dosages, which is particularly important during and after surgical procedures. As healthcare facilities deal with increasing volumes of patients, the demand for sophisticated infusion systems in hospitals is on the rise.
Increasing Home Healthcare Trend is Propelling the Market Growth
There is a significant trend towards home-based care, fueled by the demand for affordable treatment, patient comfort, and the development of portable medical devices. Home infusion pumps are compact, user-friendly, and enable patients to receive therapies such as insulin infusion, pain management, and chemotherapy without the need to go to a hospital.
For Instance, as estimated by the U.S. Census Bureau, in 2030, all members of the baby boomer generation will be aged 65 and above, making up 21% of the population compared to 16% in 2016. The 65-and-older age group is expected to be around 73 million by then. Going even further into the future, the aged population will increase to 80 million by 2050, with persons aged 65 and above (77 million) outnumbering children under 18 (76.5 million).
This is especially beneficial for old patients or patients with chronic illnesses that require treatment over the long term. Expansion of telemedicine services and facilitating insurance policies also increases the utilization of infusion pumps in homecare environments.
Restraint
High Cost of Infusion Pump Devices and Maintenance is Restraining the Infusion Pump Market Trends
Sophisticated infusion pumps, especially smart pumps with warning alerts and connectivity, are expensive. The cost incurs not just the upfront cost but also regular maintenance, calibration, patches to the software, and employee training. It is a drawback to small hospitals and clinics, as well as to low- and middle-income countries.
By Type
In 2024, the insulin pumps segment dominated the global infusion pump market share with around 36.80%, driven mainly by the rising burden of diabetes and the growing use of sophisticated insulin delivery systems. Insulin pumps have numerous benefits over classic multiple daily injections, such as more accurate insulin dosing, enhanced glycemic control, and improved quality of life for patients. The convergence of insulin pumps with continuous glucose monitoring (CGM) systems has also evolved diabetes management, where real-time adjustments are made and improved disease control is ensured.
For Instance, in August 2023, the FDA approved the Accu-Chek Solo micropump system, which consists of a tubeless insulin pump and a wireless handheld controller with Bluetooth. The controller is paired with blood glucose monitoring and gives bolus dosing recommendations.
The segment of insulin pumps is expected to grow at the fastest rate in the infusion pump market. This anticipated growth is driven by continued innovation in pump technology, such as the development of hybrid closed-loop systems that are capable of automating insulin delivery based on real-time glucose levels. In addition, increasing interest in personalized medicine and demand for home-based diabetes management solutions are also expected to continue driving the use of insulin pumps. With the healthcare systems around the globe concentrating on improved patient outcomes and effective treatments, insulin pumps are bound to play a deciding role in the future of diabetes care.
By Application
In 2024, the Diabetes segment led the infusion pump market with a market share of 52.14%, driven by increasing cases of diabetes and increased application of advanced insulin delivery systems.
According to the International Diabetes Federation estimates, in the year 2021, an estimated 537 million adults aged 20–79 years suffered from diabetes; by the year 2045, that number is estimated to rise to 783 million.
This spurt highlights the increased need for efficacious diabetes control solutions, leading to the prominence of the diabetes application segment within the infusion pump market. The diabetes application segment is anticipated to witness the fastest growth within the infusion pump market. Contributing factors to this projected growth are technology advances such as the merging of insulin pumps with continuous glucose monitoring (CGM) systems, closed-loop hybrid system development, and growing access to reimbursement policies favoring the use of such devices. These technologies improve the accuracy and ease of insulin delivery, making them more desirable to patients and medical professionals alike.
By End User
The hospitals segment dominated the infusion pump market with a 48.15% market share in 2024, mainly due to the sheer volume of medical treatments and procedures calling for accurate medication and fluid delivery. Infusion pumps are most consumed by Hospitals, which make up the most significant share in their usage since they are utilized in caring for critical care patients, such as those with cancer, diabetes, and other diseases. The hospitals' demand for infusion pumps is further driven by the need for various types of pumps, such as volumetric, syringe, and PCA pumps, to accommodate a range of therapies from anesthesia to pain management. Hospitals increasingly implement advanced features on smart infusion systems, including increased accuracy and patient safety, solidifying their position as market leaders.
The home care settings segment will exhibit the fastest growth in the forecast period with a 7.89% CAGR, due to the rising need for home-based healthcare service options. The expanding elderly population, rising incidence of chronic diseases such as diabetes, and the evolution of portable and user-friendly infusion technology are key factors driving this trend. Homecare environments provide patients with more comfort, convenience, and autonomy to control their treatment, particularly in diseases involving long-term infusion therapy, such as diabetes and pain management.
For instance, the need for home healthcare is increasing much more rapidly than the supply of available caregivers, creating a chronic workforce shortage. The home care workforce will need to grow by 34% from 2019 to 2029 to meet the increasing demand, as projected by the U.S. Bureau of Labor Statistics.
North America dominated the infusion pump market with approximately 38.12% market share in 2024 due to its developed healthcare infrastructure, high healthcare expenditure, and early adoption of advanced medical technologies. The region houses some of the top players of the market, such as BD, Baxter, Medtronic, and ICU Medical, which invest heavily in innovation and product development.
In March 2022, healthcare technology global leader Medtronic plc launched in the U.S. its Medtronic Extended infusion set—the first and only infusion set indicated for up to 7-day wear. Infusion sets have historically been replaced every two or three days, as they transfer insulin from the pump to the body. This innovation is now available exclusively to users of the MiniMed 600 and 700 series insulin pumps.
Additionally, the pervasive prevalence of chronic diseases such as diabetes and cancer, coupled with increasing aging populations, spurs recurrent demand for infusion therapies. Facilitative regulatory environments, such as recurrent FDA approvals, also contribute to infusion pump market analysis and grant instant access to more recent devices.
Asia Pacific is the fastest-growing region in the infusion pump market with a 7.98% CAGR over the forecast period, driven by quick advancements in healthcare infrastructure, rising awareness of managing chronic diseases, and growth in a middle-class population with better access to medical services. China, India, and Japan are experiencing a boom in hospital investment and home healthcare services, driving the demand for portable and sophisticated infusion devices. Additionally, positive government policies towards increasing healthcare access and the increasing disease burden of conditions such as diabetes are driving adoption rates, making Asia Pacific a growth driver for the global market.
Europe is a leading player in the global infusion pump market, with its highly developed healthcare infrastructure, aging population, and high incidence of chronic diseases such as diabetes and cancer. Germany, the UK, and France are among the key contributors to market growth due to their strong healthcare systems and rising focus on patient-centered care.
Germany dominates the infusion pumps market in Europe owing to its developed healthcare system, the strong dominance of large players such as B. Braun Melsungen AG and Fresenius Kabi, and the uncontrolled demand for accurate medical technology. The chronic disease management emphasis of the country, including cancers and diabetes, results in frequent consumption of infusion therapy products.
Latin America exhibits moderate growth in the infusion pump market due to a growing incidence of chronic diseases such as diabetes and cancer, and an aging population. Brazil, Mexico, and Argentina are leading the development of healthcare infrastructure and the uptake of infusion technologies, especially in homecare and outpatient environments.
The Middle East & Africa region is also experiencing consistent growth as access to healthcare continues to improve and demand for sophisticated medical devices increases. The UAE, Saudi Arabia, and Egypt are investing in upgrading their healthcare infrastructures and adopting portable and intelligent infusion solutions. However, exorbitant device prices and compliance issues in less developed regions could moderate overall market development.
The infusion pump market companies include Becton, Dickinson and Company (BD), Baxter International Inc., Medtronic plc, Fresenius Kabi, ICU Medical, Inc., Smiths Medical, Terumo Corporation, Moog Inc., Nipro Corporation, Zyno Medical LLC, and other players.
July 21, 2023 – BD (Becton, Dickinson and Company), a medical technology global leader, has announced that its new BD Alaris Infusion System received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The clearance will aid remediation and the full commercial reintroduction of the most extensive infusion system available in the United States.
April 2024 – Baxter International Inc., a global leader in infusion therapies and technologies, has announced that it has received FDA 510(k) clearance for its Novum IQ Large Volume Infusion Pump (LVP) combined with Dose IQ Safety Software to support the safety and efficiency of infusion therapy delivery in the clinical environment.
| Report Attributes | Details |
|---|---|
| Market Size in 2024 | USD 13.12 Billion |
| Market Size by 2032 | USD 23.13 Billion |
| CAGR | CAGR of 7.32% From 2025 to 2032 |
| Base Year | 2024 |
| Forecast Period | 2025-2032 |
| Historical Data | 2021-2023 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Type (Volumetric Pumps, Syringe Pumps, Elastomeric Pumps, Insulin Pumps, Enteral Pumps, Implantable Pumps, Patient Control Analgesia (PCA) Pumps) • By Application (Diabetes, Oncology, Pain Management, Others) • By End User (Hospitals, Ambulatory Care Settings, Specialty Clinics, Home Care Settings) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Becton, Dickinson and Company (BD), Baxter International Inc., Medtronic plc, Fresenius Kabi, ICU Medical, Inc., Smiths Medical, Terumo Corporation, Moog Inc., Nipro Corporation, Zyno Medical LLC, and other players. |
Ans: The Infusion Pump Market is expected to grow at a CAGR of 7.32% from 2025 to 2032.
Ans: The Infusion Pump Market was USD 13.12 billion in 2024 and is expected to reach USD 23.13 billion by 2032.
Ans: Hospital admission and surgery rates increase are driving the market growth.
Ans: The “Diabetes” segment dominated the Infusion Pump Market.
Ans: North America dominated the Infusion Pump Market in 2024.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence Trends (2024)
5.2 Prescription and Utilization Trends (2024), by Region
5.3 Healthcare Expenditure on Infusion Therapy, by Region (2024)
5.4 Technological Advancements and Smart Pump Adoption (2020–2024)
5.5 Regulatory Landscape and FDA Approvals (2020–2024)
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Infusion Pump Market Segmentation By Type
7.1 Chapter Overview
7.2 Volumetric Pumps
7.2.1 Volumetric Pumps Market Trends Analysis (2021-2032)
7.2.2 Volumetric Pumps Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Syringe Pumps
7.3.1 Syringe Pumps Market Trends Analysis (2021-2032)
7.3.2 Syringe Pumps Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Elastomeric Pumps
7.4.1 Elastomeric Pumps Market Trends Analysis (2021-2032)
7.4.2 Elastomeric Pumps Market Size Estimates and Forecasts to 2032 (USD Billion)
7.5 Insulin Pumps
7.5.1 Insulin Pumps Market Trends Analysis (2021-2032)
7.5.2 Insulin Pumps Market Size Estimates and Forecasts to 2032 (USD Billion)
7.6 Enteral Pumps
7.6.1 Enteral Pumps Market Trends Analysis (2021-2032)
7.6.2 Enteral Pumps Market Size Estimates and Forecasts to 2032 (USD Billion)
7.7 Implantable Pumps
7.7.1 Implantable Pumps Market Trends Analysis (2021-2032)
7.7.2 Implantable Pumps Market Size Estimates and Forecasts to 2032 (USD Billion)
7.8 Patient Control Analgesia (PCA) Pumps
7.8.1 Patient Control Analgesia (PCA) Pumps Market Trends Analysis (2021-2032)
7.8.2 Patient Control Analgesia (PCA) Pumps Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Infusion Pumps Market Segmentation By Application
8.1 Chapter Overview
8.2 Diabetes
8.2.1 Diabetes Market Trend Analysis (2021-2032)
8.2.2 Diabetes Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Oncology
8.3.1 Oncology Market Trends Analysis (2021-2032)
8.3.2 Oncology Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Pain Management
8.4.1 Pain Management Market Trends Analysis (2021-2032)
8.4.2 Pain Management Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Others
8.5.1 Other Market Trends Analysis (2021-2032)
8.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Infusion Pumps Market Segmentation By End User
9.1 Chapter Overview
9.2 Hospitals
9.2.1 Hospitals Market Trends Analysis (2021-2032)
9.2.2 Hospitals Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Ambulatory Care Settings
9.3.1 Ambulatory Care Settings Market Trends Analysis (2021-2032)
9.3.2 Ambulatory Care Settings Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Specialty Clinics
9.4.1 Specialty Clinics Market Trends Analysis (2021-2032)
9.4.2 Specialty Clinics Market Size Estimates and Forecasts to 2032 (USD Billion)
9.5 Home Care Settings
9.5.1 Home Care Settings Market Trends Analysis (2021-2032)
9.5.2 Home Care Settings Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Infusion Pumps Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.2.3 North America Infusion Pumps Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.2.4 North America Infusion Pumps Market Estimates and Forecasts, by Application (2021-2032) (USD Billion)
10.2.5 North America Infusion Pumps Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA Infusion Pumps Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.2.6.2 USA Infusion Pumps Market Estimates and Forecasts, by Application (2021-2032) (USD Billion)
10.2.6.3 USA Infusion Pumps Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada Infusion Pumps Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.2.7.2 Canada Infusion Pumps Market Estimates and Forecasts, by Application (2021-2032) (USD Billion)
10.2.7.3 Canada Infusion Pumps Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico Infusion Pumps Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.2.8.2 Mexico Infusion Pumps Market Estimates and Forecasts, by Application (2021-2032) (USD Billion)
10.2.8.3 Mexico Infusion Pumps Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
10.3 Europe
10.3.1 Trends Analysis
10.3.2 Europe Infusion Pumps Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.3.3 Europe Infusion Pumps Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.3.4 Europe Infusion Pumps Market Estimates and Forecasts, by Application (2021-2032) (USD Billion)
10.3.5 Europe Infusion Pumps Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
10.3.6 Germany
10.3.6.1 Germany Infusion Pumps Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.3.6.2 Germany Infusion Pumps Market Estimates and Forecasts, by Application (2021-2032) (USD Billion)
10.3.6.3 Germany Infusion Pumps Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
10.3.7 France
10.3.7.1 France Infusion Pumps Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.3.7.2 France Infusion Pumps Market Estimates and Forecasts, by Application (2021-2032) (USD Billion)
10.3.7.3 France Infusion Pumps Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
10.3.8 UK
10.3.8.1 UK Infusion Pumps Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.3.8.2 UK Infusion Pumps Market Estimates and Forecasts, by Application (2021-2032) (USD Billion)
10.3.8.3 UK Infusion Pumps Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
10.3.9 Italy
10.3.9.1 Italy Infusion Pumps Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.3.9.2 Italy Infusion Pumps Market Estimates and Forecasts, by Application (2021-2032) (USD Billion)
10.3.9.3 Italy Infusion Pumps Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
10.3.10 Spain
10.3.10.1 Spain Infusion Pumps Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.3.10.2 Spain Infusion Pumps Market Estimates and Forecasts, by Application (2021-2032) (USD Billion)
10.3.10.3 Spain Infusion Pumps Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
10.3.11 Poland
10.3.11.1 Poland Infusion Pumps Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.3.11.2 Poland Infusion Pumps Market Estimates and Forecasts, by Application (2021-2032) (USD Billion)
10.3.11.3 Poland Infusion Pumps Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
10.3.12 Turkey
10.3.12.1 Turkey Infusion Pumps Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.3.12.2 Turkey Infusion Pumps Market Estimates and Forecasts, by Application (2021-2032) (USD Billion)
10.3.12.3 Turkey Infusion Pumps Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
10.3.13 Rest of Europe
10.3.13.1 Rest of Europe Infusion Pumps Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.3.13.2 Rest of Europe Infusion Pumps Market Estimates and Forecasts, by Application (2021-2032) (USD Billion)
10.3.13.3 Rest of Europe Infusion Pumps Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
10.4 Asia Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific Infusion Pumps Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.4.3 Asia Pacific Infusion Pumps Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.4.4 Asia Pacific Infusion Pumps Market Estimates and Forecasts, by Application (2021-2032) (USD Billion)
10.4.5 Asia Pacific Infusion Pumps Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
10.4.6 China
10.4.6.1 China Infusion Pumps Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.4.6.2 China Infusion Pumps Market Estimates and Forecasts, by Application (2021-2032) (USD Billion)
10.4.6.3 China Infusion Pumps Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
10.4.7 India
10.4.7.1 India Infusion Pumps Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.4.7.2 India Infusion Pumps Market Estimates and Forecasts, by Application (2021-2032) (USD Billion)
10.4.7.3 India Infusion Pumps Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan Infusion Pumps Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.4.8.2 Japan Infusion Pumps Market Estimates and Forecasts, by Application (2021-2032) (USD Billion)
10.4.8.3 Japan Infusion Pumps Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea Infusion Pumps Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.4.9.2 South Korea Infusion Pumps Market Estimates and Forecasts, by Application (2021-2032) (USD Billion)
10.4.9.3 South Korea Infusion Pumps Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
10.4.10 Singapore
10.4.10.1 Singapore Infusion Pumps Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.4.10.2 Singapore Infusion Pumps Market Estimates and Forecasts, by Application (2021-2032) (USD Billion)
10.4.10.3 Singapore Infusion Pumps Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
10.4.11 Australia
10.4.11.1 Australia Infusion Pumps Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.4.11.2 Australia Infusion Pumps Market Estimates and Forecasts, by Application (2021-2032) (USD Billion)
10.4.11.3 Australia Infusion Pumps Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
10.4.12 Rest of Asia Pacific
10.4.12.1 Rest of Asia Pacific Infusion Pumps Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.4.12.2 Rest of Asia Pacific Infusion Pumps Market Estimates and Forecasts, by Application (2021-2032) (USD Billion)
10.4.12.3 Rest of Asia Pacific Infusion Pumps Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Trends Analysis
10.5.2 Middle East and Africa Infusion Pumps Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.5.3 Middle East and Africa Infusion Pumps Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.5.4 Middle East and Africa Infusion Pumps Market Estimates and Forecasts, by Application (2021-2032) (USD Billion)
10.5.5 Middle East and Africa Infusion Pumps Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
10.5.6 UAE
10.5.6.1 UAE Infusion Pumps Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.5.6.2 UAE Infusion Pumps Market Estimates and Forecasts, by Application (2021-2032) (USD Billion)
10.5.6.3 UAE Infusion Pumps Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
10.5.7 Saudi Arabia
10.5.7.1 Saudi Arabia Infusion Pumps Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.5.7.2 Saudi Arabia Infusion Pumps Market Estimates and Forecasts, by Application (2021-2032) (USD Billion)
10.5.7.3 Saudi Arabia Infusion Pumps Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
10.5.8 Qatar
10.5.8.1 Qatar Infusion Pumps Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.5.8.2 Qatar Infusion Pumps Market Estimates and Forecasts, by Application (2021-2032) (USD Billion)
10.5.8.3 Qatar Infusion Pumps Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
10.5.9 South Africa
10.5.9.1 South Africa Infusion Pumps Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.5.9.2 South Africa Infusion Pumps Market Estimates and Forecasts by Application (2021-2032) (USD Billion)
10.5.9.3 South Africa Infusion Pumps Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
10.5.10 Rest of Middle East & Africa
10.5.10.1 Rest of Middle East & Africa Infusion Pumps Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.5.10.2 Rest of Middle East & Africa Infusion Pumps Market Estimates and Forecasts, by Application (2021-2032) (USD Billion)
10.5.10.3 Rest of Middle East & Africa Infusion Pumps Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Infusion Pumps Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.6.3 Latin America Infusion Pumps Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.6.4 Latin America Infusion Pumps Market Estimates and Forecasts, by Application (2021-2032) (USD Billion)
10.6.5 Latin America Infusion Pumps Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil Infusion Pumps Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.6.6.2 Brazil Infusion Pumps Market Estimates and Forecasts, by Application (2021-2032) (USD Billion)
10.6.6.3 Brazil Infusion Pumps Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina Infusion Pumps Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.6.7.2 Argentina Infusion Pumps Market Estimates and Forecasts, by Application (2021-2032) (USD Billion)
10.6.7.3 Argentina Infusion Pumps Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
10.6.8 Rest of Latin America
10.6.8.1 Rest of Latin America Infusion Pumps Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.6.8.2 Rest of Latin America Infusion Pumps Market Estimates and Forecasts, by Application (2021-2032) (USD Billion)
10.6.8.3 Rest of Latin America Infusion Pumps Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
11. Company Profiles
11.1 Becton, Dickinson and Company (BD)
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Product/ Services Offered
11.1.4 SWOT Analysis
11.2 Baxter International Inc.
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Product/ Services Offered
11.2.4 SWOT Analysis
11.3 Medtronic plc
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Product/ Services Offered
11.3.4 SWOT Analysis
11.4 Fresenius Kabi
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Product/ Services Offered
11.4.4 SWOT Analysis
11.5 ICU Medical, Inc.
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Product/ Services Offered
11.5.4 SWOT Analysis
11.6 Smiths Medical
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Product/ Services Offered
11.6.4 SWOT Analysis
11.7 Terumo Corporation
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Product/ Services Offered
11.7.4 SWOT Analysis
11.8 Moog Inc.
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Product/ Services Offered
11.8.4 SWOT Analysis
11.9 Nipro Corporation
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Product/ Services Offered
11.9.4 SWOT Analysis
11.10 Zyno Medical LLC.
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Product/ Services Offered
11.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments:
By Type
Volumetric Pumps
Syringe Pumps
Elastomeric Pumps
Insulin Pumps
Enteral Pumps
Implantable Pumps
Patient Control Analgesia (PCA) Pumps
By Application
Diabetes
Oncology
Pain Management
Others
By End User
Hospitals
Ambulatory Care Settings
Specialty Clinics
Home Care Settings
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Poland
Turkey
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
UAE
Saudi Arabia
Qatar
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players
